Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

247 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Enhanced engraftment of human myelofibrosis stem and progenitor cells in MISTRG mice.
Lysenko V, Wildner-Verhey van Wijk N, Zimmermann K, Weller MC, Bühler M, Wildschut MHE, Schürch P, Fritz C, Wagner U, Calabresi L, Psaila B, Flavell RA, Vannucchi AM, Mead AJ, Wild PJ, Dirnhofer S, Manz MG, Theocharides APA. Lysenko V, et al. Among authors: calabresi l. Blood Adv. 2020 Jun 9;4(11):2477-2488. doi: 10.1182/bloodadvances.2019001364. Blood Adv. 2020. PMID: 32502268 Free PMC article.
CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles.
Zini R, Guglielmelli P, Pietra D, Rumi E, Rossi C, Rontauroli S, Genovese E, Fanelli T, Calabresi L, Bianchi E, Salati S, Cazzola M, Tagliafico E, Vannucchi AM, Manfredini R; AGIMM (AIRC Gruppo Italiano Malattie Mieloproliferative) investigators. Zini R, et al. Among authors: calabresi l. Blood Cancer J. 2017 Dec 8;7(12):638. doi: 10.1038/s41408-017-0010-2. Blood Cancer J. 2017. PMID: 29217833 Free PMC article.
Extramedullary blastic transformation of primary myelofibrosis in the form of disseminated myeloid sarcoma: a case report and review of the literature.
Coltro G, Mannelli F, Vergoni F, Santi R, Massi D, Siliani LM, Marzullo A, Bonifacio S, Pelo E, Pacilli A, Paoli C, Franci A, Calabresi L, Bosi A, Vannucchi AM, Guglielmelli P. Coltro G, et al. Among authors: calabresi l. Clin Exp Med. 2020 May;20(2):313-320. doi: 10.1007/s10238-020-00616-5. Epub 2020 Feb 17. Clin Exp Med. 2020. PMID: 32065308 Review.
Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants.
Salati S, Genovese E, Carretta C, Zini R, Bartalucci N, Prudente Z, Pennucci V, Ruberti S, Rossi C, Rontauroli S, Enzo E, Calabresi L, Balliu M, Mannarelli C, Bianchi E, Guglielmelli P, Tagliafico E, Vannucchi AM, Manfredini R. Salati S, et al. Among authors: calabresi l. Sci Rep. 2019 Jul 22;9(1):10558. doi: 10.1038/s41598-019-46843-z. Sci Rep. 2019. PMID: 31332222 Free PMC article.
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value.
Vannucchi AM, Rotunno G, Bartalucci N, Raugei G, Carrai V, Balliu M, Mannarelli C, Pacilli A, Calabresi L, Fjerza R, Pieri L, Bosi A, Manfredini R, Guglielmelli P. Vannucchi AM, et al. Among authors: calabresi l. Leukemia. 2014 Sep;28(9):1811-8. doi: 10.1038/leu.2014.100. Epub 2014 Mar 12. Leukemia. 2014. PMID: 24618731 Free PMC article.
The MPL mutation.
Guglielmelli P, Calabresi L. Guglielmelli P, et al. Among authors: calabresi l. Int Rev Cell Mol Biol. 2021;365:163-178. doi: 10.1016/bs.ircmb.2021.09.003. Epub 2021 Oct 2. Int Rev Cell Mol Biol. 2021. PMID: 34756243 Review.
247 results